Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

157.47 +0.81 (+0.52%)
Streaming Delayed Price Updated: 11:55 AM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,088,804
Open 155.97
Bid (Size) 157.47 (1)
Ask (Size) 157.50 (2)
Prev. Close 156.66
Today's Range 155.97 - 157.60
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?
Via The Motley Fool
Topics Lawsuit
Exposures Financial Legal
If I Could Invest $1,000 in Any Growth Stock, It Would Be This One
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political

Performance

YTD
+9.3%
+9.3%
1 Month
+6.1%
+6.1%
3 Month
-3.4%
-3.4%
6 Month
+7.7%
+7.7%
1 Year
+8.3%
+8.3%

More News

Read More
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Via The Motley Fool
Topics Economy
Exposures Economy
Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
From Johnson & Johnson
Via Business Wire
12 Analysts Have This To Say About Johnson & Johnson
Via Benzinga
P/E Ratio Insights for Johnson & Johnson
Via Benzinga
Rep. Gilbert Ray Cisneros Has Bought Up to $410K Worth Of Johnson & Johnson Stock: Here's What You Should Know
Via Benzinga
3 Top Dividend Stocks Analysts Are Bullish on Right Now
Via MarketBeat
Topics ETFs
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Via Benzinga
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
Via Benzinga
Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentation
Via Benzinga
5 Cheap Stocks to Buy in June
Via The Motley Fool
Top 3 Reasons Savvy Investors Are Buying Johnson & Johnson Stock While Others Panic Over Lawsuits
Via Talk Markets
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire
Via Investor's Business Daily
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row
Via The Motley Fool
Topics Bonds
Exposures Debt Markets
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
Why Is Teva Stock Trading Higher On Tuesday?
Via Benzinga
Why Dan Loeb Just Made Kenvue One Of His Top Holdings
Via Benzinga
1 Top Dividend Stock to Buy for a Lifetime of Passive Income
Via The Motley Fool
Topics Economy Lawsuit
Exposures Economy Financial Legal
Johnson & Johnson (NYSE:JNJ) – A Reliable Dividend Stock Worth Considering
Via Chartmill
Investing for Passive Income? Here's What History Says About the Stability of Dividend King Stocks.
Via The Motley Fool
Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond
Via The Motley Fool
Topics Bonds Stocks
Exposures Debt Markets US Equities
Elon Musk Commits to Tesla. Is That a Good Thing?
Via The Motley Fool
Value Investing Is Not Dead - It Just Got Smarter
Via Benzinga
FDA Panel Reiterates the Cancer Risks of Talc
From Beasley Allen Law Firm
Via Business Wire

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 157.47
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 06/13/25 11:55 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 413.94B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 414B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.